Uploaded October 2026 | Updated November 2026, 3 hours ago
October is Breast Cancer Awareness Month. While much of the conversation focuses on diagnosis and treatment, millions of survivors are left wondering, "Will my cancer come back?" Today we're looking at how a personalized blood test may help patients and their doctors monitor for recurrence after treatment. Chance Osborne, a triple-negative breast cancer survivor who was diagnosed at age 24, and Dr. Noam Drazin, a medical oncologist with Cedars-Sinai discuss this new ground-breaking technology.
October is Breast Cancer Awareness Month. While much of the conversation focuses on diagnosis and treatment, millions of survivors are left wondering, "Will my cancer come back?" Today we're looking at how a personalized blood test may help patients and their doctors monitor for recurrence after treatment. Chance Osborne, a triple-negative breast cancer survivor who was diagnosed at age 24, and Dr. Noam Drazin, a medical oncologist with Cedars-Sinai discuss this new ground-breaking technology.










